Sinocare Inc. Stock Analysis 300298.SZ

Sinocare, Inc. engages in the development, production and sale of chronic disease rapid detection products. The Company’s main products include blood glucose monitoring systems, diabetes nutrition and nursing support products, lipid profile monitoring systems, intelligent point-of-care (iPOCT) monitoring systems, glycated hemoglobin testing systems, blood pressure monitors and others. The firm is also engaged in providing systematic chronic disease assessments, standardized treatments, comprehensive in-hospital and out-of-hospital health management, knowledge education, and psychological counseling services to patients with metabolic diseases such as diabetes, obesity, and hyperuricemia. The firm conducts its business in the domestic and overseas markets.